Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 20;18(15):1269-1271.
doi: 10.4244/EIJ-D-22-00675.

Cangrelor for comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention: the CANGRELOR-OHCA study

Peter Kordis  1   2 , Mojca Bozic Mijovski  3 , Jernej Berden  1   2 , Klemen Steblovnik  2   4 , Ales Blinc  2   3 , Marko Noc  1   2
Affiliations

Cangrelor for comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention: the CANGRELOR-OHCA study

Peter Kordis et al. EuroIntervention. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare related to this study.

Figures

Figure 1
Figure 1. Cangrelor-induced platelet inhibition in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and target temperature management.
Platelet reactivity and high on-treatment platelet reactivity (HPR) measured at baseline and at 1, 3, 5 and 8 hours after passage of PCI guidewire according to VerifyNow P2Y12 (A, B) and Multiplate ADP (C, D) in cangrelor and control groups. ADP: adenosine-diphosphate; PCI: percutaneous coronary intervention; PRU: platelet reactivity units; SD: standard deviation
See this image and copyright information in PMC

References

    1. Rauber M, Nicol P, Sabic E, Joner M, Noc M. Timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and therapeutic hypothermia (ST-OHCA study). EuroIntervention. 2022 Oct 21;18(9):740–8. - PMC - PubMed
    1. Steblovnik K, Blinc A, Bozic Mijovski, Fister M, Mikuz U, Noc M. Ticagrelor Versus Clopidogrel in Comatose Survivors of Out-of-Hospital Cardiac Arrest Undergoing Percutaneous Coronary Intervention and Hypothermia: A Randomized Study. Circulation. 2016;134:2128–30. - PubMed
    1. Noc M, Fajadet J, Lassen JF, Kala P, MacCarthy P, Olivecrona GK, Windecker S, Spaulding C European Association for Percutaneous Cardiovascular Interventions (EAPCI); Stent for Life (SFL) Group. Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European association for percutaneous cardiovascular interventions (EAPCI)/stent for life (SFL) groups. EuroIntervention. 2014;10:31–7. - PubMed
    1. Knafelj R, Radsel P, Ploj T, Noc M. Primary percutaneous coronary intervention and mild induced hypothermia in comatose survivors of ventricular fibrillation with ST-elevation acute myocardial infarction. Resuscitation. 2007;74:227–34. - PubMed
    1. Franchi F, Rollini F, Rivas A, Wali M, Briceno M, Agarwal M, Shaikh Z, Nawaz A, Silva G, Been L, Smairat R, Kaufman M, Pineda AM, Suryadevara S, Soffer D, Zenni MM, Bass TA, Angiolillo DJ. Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Circulation. 2019;139:1661–70. - PubMed